[ SNSF - Investigator initiated clinical trials | Research funding ]

The SNSF launches the fourth “Investigator initiated clinical trials (IICT)” call. This programme supports independent clinical studies. The call is limited to prospective, randomised, controlled, interventional, multicentric studies of new or existing treatments on subjects that are not in the industry focus and therefore insufficiently researched. The studies are of high clinical relevance and public importance.
 
No funding will be awarded for: in particular, pilot studies, proof of concept studies, translational studies, observation studies, studies involving healthy subjects, and physiological or pathophysiological studies of patients. Also excluded are phase I and phase IIa pharmaceutical studies as well as combined studies with a phase I - or phase IIa - component. Funding for such studies can be applied for under the project funding scheme. In addition, technology development for new treatments and the development and evaluation of new diagnostic or risk-stratified procedures without a therapy component will not be funded. Studies conducted for directly commercial purposes are also excluded.
 
Who can apply:

• Consortium: max. 5 applicants with an excellent scientific track record over several years and the ability to lead a clinical study involving various experts and institutions in a multicentric setting.
• Applicants: PhD obtained at least 4 years prior to the application deadline or 3 years of research work. This restriction does not apply to independent researchers who can apply as soon as they get the said position. Applicants must be established researchers: all applicants must be in a position to carry out research projects under their own responsibility and to lead project staff. Applicants must comply with art.10-12 of SNSF Funding Regulations and be employed at a Swiss academic institutions for the duration of the project.